News, Articles and Updates
News
NYU Langone AI tool predicts PTSD risk from ER patient narratives: Study
New York City-based NYU Langone Health researchers have developed an AI tool that predicts which emergency department trauma patients will develop post-traumatic stress disorder based on patients’ answers to the routine intake question of what brought them to the ED, according to a study published…
Texas forensic psych bed waitlist tops 1,600 amid $650M repair backlog
There were 1,626 people waiting for forensic state hospital beds at the end of fiscal year 2026, down from 1,734 in the first quarter, according to a November report from the Texas Health and Human Services Commission. The forensic waitlist covers people found incompetent to…
Compass Pathways’ psilocybin drug application heads to the FDA
Biotechnology company Compass Pathways has completed its new drug application to the FDA for COMP360, an investigational synthetic psilocybin formulation for treatment-resistant depression, the company said Nov. 9. The application rests on two phase 3 trials and a phase 2b study. Each met its primary…
Ohio warns of mislabeled cat’s claw supplements containing synthetic kratom
Ohio Gov. Mike DeWine and Attorney General Andy Wilson announced a public bulletin Nov. 6 warning that some products sold as dietary supplements, particularly those labeled as the herb cat’s claw, contain synthetic kratom and other illegal drugs. The Ohio Narcotics Intelligence Center and the…
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
New data shows cannabis dominates teens’ substance-related ER visits, often with alcohol or stimulants, urging better screening and intervention for psychosis, vomiting. — From Psychiatric Times articles Read More
Death, Taxes, and Envy: Treating Creative Patients
How can you address envy in your creative patients? — From Psychiatric Times articles Read More
The Last Times
”A tearful handshake, Steps shuffle out the doorway, My career closes…” — From Psychiatric Times articles Read More
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
Compass Pathways has completed its submission of an NDA to the FDA for COMP360 psilocybin for treatment-resistant depression. — From Psychiatric Times articles Read More
Shared Decision-Making in MDD Treatment Across the Lifespan
Patients weigh trade-offs differently than clinicians do, and they arrive having already consulted the internet. The panel examines what to honor in shared decision-making without sacrificing the evidence. — From Psychiatric Times articles Read More
The MDD Pipeline: New Mechanisms Beyond the Monoamine Model
The field finally has new targets after decades anchored to monoamines. Dr. DeBattista explains why he welcomes them while predicting, from experience, that most of them will not work out. — From Psychiatric Times articles Read More
Functional Unblinding and Its Implications for the Internal Validity of Randomized Controlled Clinical Trials: The Science May Be Nuanced
Original Source: Journal of Clinical Psychiatry, all rights reserved. — The abbreviation RCT expands to “randomized controlled trial”; in medical intervention contexts, it effects. expands more specifically to “randomized clinical trial”; the latter is a subset of the former. The RCT is a gold-standard research…
The American Society of Clinical Psychopharmacology Task Force Consensus Statement on Combination Psychopharmacology
Original Source: Journal of Clinical Psychiatry, all rights reserved. — Combination psychopharmacology has become increasingly commonplace in clinical practice. Since the late 1990s, single- or even dual-agent regimens for patients with serious mental illnesses (SMIs) have become increasingly rare in real-world practice settings, with substantial…
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT